Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2025-12-30 00:00:00 ET · period of report 2025-12-29 · accession 0001712276-25-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-30 | 2025-12-29 | RXRX | Taylor Ben R | CFO | S - Sale | $4.18 | -21.4K | 761.5K | -3% | -$89.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-12-29 | S | D | 21,383 | $4.18 | 761,550 | D | — | — |